ID23504A - Komposi-komposi farmasi yang mengandung vitamin d dan kalsium, pembuatan dan penggunaan terapinya - Google Patents

Komposi-komposi farmasi yang mengandung vitamin d dan kalsium, pembuatan dan penggunaan terapinya

Info

Publication number
ID23504A
ID23504A IDW20000401A ID20000401A ID23504A ID 23504 A ID23504 A ID 23504A ID W20000401 A IDW20000401 A ID W20000401A ID 20000401 A ID20000401 A ID 20000401A ID 23504 A ID23504 A ID 23504A
Authority
ID
Indonesia
Prior art keywords
calcium
composions
pharmacy
therapy
making
Prior art date
Application number
IDW20000401A
Other languages
English (en)
Inventor
Valleri Maurizio
Tosetti Alessandro
Original Assignee
Menarini Int Operations Lu Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Int Operations Lu Sa filed Critical Menarini Int Operations Lu Sa
Publication of ID23504A publication Critical patent/ID23504A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20000401A 1997-07-30 1998-07-21 Komposi-komposi farmasi yang mengandung vitamin d dan kalsium, pembuatan dan penggunaan terapinya ID23504A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97FI000184A ITFI970184A1 (it) 1997-07-30 1997-07-30 Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico

Publications (1)

Publication Number Publication Date
ID23504A true ID23504A (id) 2000-04-27

Family

ID=11352223

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000401A ID23504A (id) 1997-07-30 1998-07-21 Komposi-komposi farmasi yang mengandung vitamin d dan kalsium, pembuatan dan penggunaan terapinya

Country Status (29)

Country Link
US (1) US7067154B1 (id)
EP (1) EP0999843B1 (id)
JP (1) JP4497496B2 (id)
KR (1) KR100573421B1 (id)
AT (1) ATE271387T1 (id)
AU (1) AU8978198A (id)
BG (1) BG65044B1 (id)
BR (1) BR9810832B1 (id)
CA (1) CA2299420C (id)
CZ (1) CZ297670B6 (id)
DE (1) DE69825164D1 (id)
EA (1) EA002492B1 (id)
EE (1) EE04046B1 (id)
ES (1) ES2223135T3 (id)
HK (1) HK1027751A1 (id)
HU (1) HU226112B1 (id)
ID (1) ID23504A (id)
IL (1) IL134268A0 (id)
IS (1) IS5359A (id)
IT (1) ITFI970184A1 (id)
NO (1) NO20000310D0 (id)
PL (1) PL189295B1 (id)
PT (1) PT999843E (id)
RS (1) RS49703B (id)
SI (1) SI0999843T1 (id)
SK (1) SK284873B6 (id)
TR (1) TR200000261T2 (id)
UA (1) UA61968C2 (id)
WO (1) WO1999006051A1 (id)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040071789A1 (en) * 2002-02-14 2004-04-15 Baron John A Calcium supplementation to reduce prostate cancer risk
ES2192136B1 (es) * 2002-01-04 2005-03-16 Italfarmaco, S.A. Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis.
ITFI20030194A1 (it) * 2003-07-17 2005-01-18 Menarini Int Operations Lu Sa Composizione farmaceutiche effervescenti contenenti
MY144631A (en) 2004-05-24 2011-10-14 Nycomed Pharma As Particulate comprising a calcium-containing compound and a sugar alcohol
BRPI0511710B8 (pt) 2004-06-01 2021-05-25 Nycomed Pharma As comprimido mastigável, sugável e deglutível contendo cálcio
DE602006001295D1 (de) 2005-02-03 2008-07-03 Nycomed Pharma As Schmelzgranulation einer zusammensetzung mit einer calziumhaltigen verbindung
JP5305374B2 (ja) 2005-02-03 2013-10-02 タケダ ニコメド エイエス カルシウム含有組成物の製造のための速い湿式凝集方法
EP1945185B1 (en) * 2005-10-12 2016-02-03 Proventiv Therapeutics, LLC Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency
UA95093C2 (uk) 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
JP5420907B2 (ja) * 2005-12-07 2014-02-19 タケダ ニコメド エイエス 予備圧縮されたカルシウム含有化合物
MXPA05014091A (es) * 2005-12-20 2007-06-20 Leopoldo De Jesus Espinosa Abdala Composiciones farmaceuticas que comprenden derivados de esteroides sinteticos, minerales y el metabolito activo de la vitamina d, 1,25(oh)2d3 (calcitriol) para la prevencion y tratamiento de la osteoporosis y el control de los sintomas de la menopaus
CA2587805C (en) * 2007-04-25 2014-02-18 The Procter & Gamble Company Improved vitamin d content uniformity in pharmaceutical dosage forms
SI2358374T1 (sl) 2008-11-17 2014-01-31 Takeda Nycomed As Izboljšana topna stabilnost tablet, ki vsebujejo kalcijev karbonat
TR200900878A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar
TR200900880A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik bileşimler.
TR200908237A2 (tr) 2009-11-02 2011-05-23 Bi̇lgi̇ç Mahmut Kalsiyum ve D vitamini içeren farmasötik bileşimler.
US20120015913A1 (en) 2010-07-15 2012-01-19 Delansorne Remi Formulations of 14-EPI-Analogues of Vitamin D
JP6554034B2 (ja) * 2013-08-09 2019-07-31 日東薬品工業株式会社 カルシウム剤
CN105166935B (zh) * 2015-09-01 2018-08-31 张伟 一种含有维生素d3的液体制剂及其制备方法
MX2020011541A (es) 2018-05-02 2020-11-24 Ferring Bv Formulaciones farmaceuticas mejoradas.
KR102211287B1 (ko) * 2018-12-21 2021-02-03 (주)휴온스 비타민 d 또는 이의 유도체를 포함하는 안정성이 개선된 액상 제제

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073271A1 (en) 1969-12-11 1971-10-01 Boivin Jean Calcium salt - vitamin d2 compn - for treatment of decalcification of
ZA813205B (en) * 1980-12-05 1983-03-30 Smith Kline French Lab Dosage units
DK8603837A (id) * 1985-08-13 1987-02-14
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
ATE147592T1 (de) * 1990-02-05 1997-02-15 Lifescience Corp Vitamine und mineralien enthaltende nahrungszusätze
WO1991018593A1 (en) * 1990-05-16 1991-12-12 Board Of Regents, The University Of Texas System Formula and method for the prevention and treatment of hypercholesterolemia and cellular hyperproliferative disorders
RO113611B1 (ro) * 1990-08-03 1998-09-30 Asta Pharma Ag Preparate solide de ifosfamida, administrate oral si procedeu de obtinere
IL103224A (en) 1992-09-18 1998-08-16 Teva Pharma Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3
FR2724844B1 (fr) 1994-09-23 1997-01-24 Innothera Lab Sa Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
FR2760639B1 (fr) * 1997-03-14 2000-09-22 Innothera Lab Sa Association therapeutique mineralo-vitaminique sous forme de preparation unitaire liquide buvable

Also Published As

Publication number Publication date
NO20000310L (no) 2000-01-21
ATE271387T1 (de) 2004-08-15
CA2299420C (en) 2009-04-21
HU226112B1 (en) 2008-04-28
KR100573421B1 (ko) 2006-04-26
ITFI970184A1 (it) 1999-01-30
JP4497496B2 (ja) 2010-07-07
RS49703B (sr) 2007-12-31
JP2001511453A (ja) 2001-08-14
KR20010022319A (ko) 2001-03-15
DE69825164D1 (de) 2004-08-26
CZ297670B6 (cs) 2007-02-28
TR200000261T2 (tr) 2000-09-21
ES2223135T3 (es) 2005-02-16
US7067154B1 (en) 2006-06-27
BG65044B1 (bg) 2007-01-31
EE200000054A (et) 2000-10-16
HK1027751A1 (en) 2001-01-23
EP0999843A1 (en) 2000-05-17
EA002492B1 (ru) 2002-06-27
PT999843E (pt) 2004-11-30
AU8978198A (en) 1999-02-22
SK284873B6 (sk) 2006-01-05
UA61968C2 (en) 2003-12-15
NO20000310D0 (no) 2000-01-21
IS5359A (is) 2000-01-24
BR9810832A (pt) 2000-07-25
YU3700A (sh) 2002-11-15
BG104057A (en) 2000-07-31
EE04046B1 (et) 2003-06-16
HUP0100539A2 (hu) 2001-08-28
CA2299420A1 (en) 1999-02-11
PL189295B1 (pl) 2005-07-29
CZ2000199A3 (cs) 2000-05-17
PL338237A1 (en) 2000-10-09
EA200000181A1 (ru) 2000-10-30
IL134268A0 (en) 2001-04-30
SI0999843T1 (en) 2005-02-28
WO1999006051A1 (en) 1999-02-11
BR9810832B1 (pt) 2010-11-16
EP0999843B1 (en) 2004-07-21
SK802000A3 (en) 2000-07-11

Similar Documents

Publication Publication Date Title
ID23504A (id) Komposi-komposi farmasi yang mengandung vitamin d dan kalsium, pembuatan dan penggunaan terapinya
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
HUP9802448A2 (hu) Vérlemezke-aggregáció inhibitorvegyületei, ezek előállítása és alkalmazása és gyógyászati készítmények
FI962154A0 (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
AU4879396A (en) Use of inorganic aerogels in pharmacy
BR0112094A (pt) Produtos de confeitaria contendo ingredientes ativos
CA2132369A1 (en) Use for the Treatment of Mixed Skins, of an Effective Quantity of Active Substances
ATE265857T1 (de) Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
HUP9801880A3 (en) Novel cryptophycins, their use and pharmaceutical compositions containing them
TR199701121T1 (xx) Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri.
SE9802937D0 (sv) Novel compounds
EP0659403A3 (en) Use of natural oil-absorbing polymer in cosmetic and pharmaceutical applications.
FR2730636B1 (fr) Huile vegetale naturelle enrichie en ozonides, compositions cosmetiques ou pharmaceutiques la contenant et utilisations
IL117760A0 (en) Taxoids, their preparation and pharmaceutical compositions containing them
NO992998L (no) Nye analoger av camptotecin, anvendelse som medikamenter og farmasöytiske blandinger som inneholder disse
ID16081A (id) Penggunaan turunan trisiklik dari 1,4-dihidro-1,4-diokso-1h-naftalena senyawa-senyawa yang diperolehnya dan penerapannya dalam terapi
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
HU9802590D0 (en) Sulfonamid-substituted and condensed compounds containing 5-membred ring, their use as medicament and pharmaceutical compositions containing them
ZA9711734B (en) Novel farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments.
BR9801839A (pt) Medicamento analgésico e aplicação de (+) -0-demetiltramadol.
FR2778101B1 (fr) Composition renfermant des oligomeres procyanidoliques (opc) et un cation divalent,son utilisation comme antifongique, composition cosmetique ou pharmaceutique,et complement alimentaire la contenant
ZA9811787B (en) Novel farnesyl transferase inhibitors, their preparation, pharmaceutical compositions which contain them and their use for the preparation of medicaments.
FR2740039B1 (fr) Utilisation d'une substance inhibant la proteine d'adhesion d'un microorganisme, composition notamment cosmetique ou therapeutique contenant cette substance
HUT75711A (en) The use of dimeticone as a transport and carrier system and/or drug delivery system, and pharmaceutical compositions containing dimeticone